Why are DMCs Important to Clinical Development?

Walter Boyle, Global Head of Axio, Cytel Inc., discusses why Data Monitoring Committees or DMCs are important to the clinical development process. The provide a safety net for participants in a clinical trials by analyzing the data that is incoming from a trial while it is progressing. Specialty DMC providers, says Boyle, can help drug sponsors ensure that they are on-top of their trials, without sacrificing patient anonymity or creating bias in clinical trial results.